BG98050A - Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат - Google Patents

Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат Download PDF

Info

Publication number
BG98050A
BG98050A BG98050A BG9805093A BG98050A BG 98050 A BG98050 A BG 98050A BG 98050 A BG98050 A BG 98050A BG 9805093 A BG9805093 A BG 9805093A BG 98050 A BG98050 A BG 98050A
Authority
BG
Bulgaria
Prior art keywords
carboxylic acid
oxoethyl
salts
organic bases
hydroxyamino
Prior art date
Application number
BG98050A
Other languages
Bulgarian (bg)
English (en)
Inventor
Raffaello Giorgi
Alessandro Subissi
Luigi Turbanti
Original Assignee
Laboratori Guidotti S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Guidotti S.P.A. filed Critical Laboratori Guidotti S.P.A.
Publication of BG98050A publication Critical patent/BG98050A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
BG98050A 1991-12-23 1993-08-18 Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат BG98050A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
PCT/EP1992/002903 WO1993013056A1 (fr) 1991-12-23 1992-12-12 Sels stables de l'acide (+)-(1s,2r)-2-[[n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino]carbonyl]cyclohexane-1-carboxylique, procede de preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
BG98050A true BG98050A (bg) 1994-04-29

Family

ID=11361409

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98050A BG98050A (bg) 1991-12-23 1993-08-18 Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат

Country Status (26)

Country Link
EP (1) EP0575572A1 (fr)
JP (1) JPH06506002A (fr)
CN (1) CN1079474A (fr)
AU (1) AU657591B2 (fr)
BG (1) BG98050A (fr)
BR (1) BR9205652A (fr)
CA (1) CA2104372A1 (fr)
CZ (1) CZ379692A3 (fr)
EE (1) EE9400006A (fr)
FI (1) FI933685A0 (fr)
HR (1) HRP921454A2 (fr)
HU (1) HUT69287A (fr)
IT (1) IT1252708B (fr)
LV (1) LV10426B (fr)
MA (1) MA22749A1 (fr)
MX (1) MX9207543A (fr)
NZ (1) NZ245547A (fr)
PL (1) PL169086B1 (fr)
PT (1) PT101156A (fr)
RU (1) RU2079489C1 (fr)
SI (1) SI9200409A (fr)
SK (1) SK379692A3 (fr)
TN (1) TNSN92117A1 (fr)
WO (1) WO1993013056A1 (fr)
YU (1) YU110892A (fr)
ZA (1) ZA9210004B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264860B1 (it) * 1993-06-21 1996-10-17 Guidotti & C Spa Labor Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
FR2817241B1 (fr) 2000-11-30 2003-03-07 Cebal Tube aluminium avec embout secable
CN101516191A (zh) * 2006-09-28 2009-08-26 默克公司 Saha的胺碱盐和其多晶型物
CN114845603B (zh) 2020-04-27 2025-01-24 卡特-霍夫曼有限责任公司 用于柜的门移动系统

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.

Also Published As

Publication number Publication date
JPH06506002A (ja) 1994-07-07
MX9207543A (es) 1993-08-01
AU657591B2 (en) 1995-03-16
AU3087192A (en) 1993-07-28
SI9200409A (en) 1993-09-30
CN1079474A (zh) 1993-12-15
ITMI913448A1 (it) 1993-06-23
RU2079489C1 (ru) 1997-05-20
MA22749A1 (fr) 1993-07-01
NZ245547A (en) 1995-12-21
LV10426B (en) 1995-08-20
FI933685L (fi) 1993-08-20
FI933685A7 (fi) 1993-08-20
CA2104372A1 (fr) 1993-06-24
EP0575572A1 (fr) 1993-12-29
ZA9210004B (en) 1993-12-13
PL297118A1 (en) 1993-09-06
HU9302389D0 (en) 1993-11-29
PT101156A (pt) 1994-06-30
SK379692A3 (en) 1995-04-12
FI933685A0 (fi) 1993-08-20
ITMI913448A0 (it) 1991-12-23
BR9205652A (pt) 1994-05-03
HRP921454A2 (en) 1995-02-28
WO1993013056A1 (fr) 1993-07-08
LV10426A (lv) 1995-02-20
EE9400006A (et) 1995-12-15
CZ379692A3 (en) 1993-09-15
HUT69287A (en) 1995-09-28
IT1252708B (it) 1995-06-26
YU110892A (sh) 1996-01-08
PL169086B1 (pl) 1996-05-31
TNSN92117A1 (fr) 1993-06-08

Similar Documents

Publication Publication Date Title
AU634319B2 (en) Amino acid derivatives
AU2009202389B2 (en) Perindopril
US4614805A (en) Bicyclic amino acids as intermediates in the preparation of tricyclic amino acids and processes for their preparation
IE60128B1 (en) Hydroxylamine derivatives,their preparation and use as medicaments
NZ206574A (en) 1-(n-(1-carboxyalkyl)-alpha-aminoalkanoyl)-octahydro2s,3as,8as-cyclohepta(b)pyrrol-2-ylcarboxylic acid derivatives
EP0572365A2 (fr) Hétéroprostanoides, procédé pour leur fabrication et utilisation thérapeutique
DE69510338T2 (de) Azirdin-derivate, deren herstellung und verwendung
US4216209A (en) Tripeptide angiotensin converting enzyme inhibitors
KR100209118B1 (ko) 벤즈아미드 유도체
CA2164296C (fr) Chimie heterocyclique
HU185022B (en) Process for the preparation of biologically active tetrapeptide derivatives
GB2077719A (en) (N-(Cycloalkyl)amino acid compounds and compositions containing same
US5420283A (en) Resolution of (R)-2-benzylsuccinic acid 4-[4-(N-t-butoxycarbonylmethylamino)-piperidine] amide
KR100312097B1 (ko) 아실페닐글리신 유도체 및 그 화합물을 유효성분으로하는,콜라게나제활성증진에기인한질환의예방및치료제
WO1989000165A1 (fr) Antiandrogenes actifs par voie orale
AU3087192A (en) Stable salts of (+)-(1S,2R)-2-((N-(2-hydroxylamino-2-oxoethyl)-N-methyl- amino)carbonyl)cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them
JP3254238B2 (ja) ホモキラルα−アミノアルデヒドのジアステレオ選択的な還元的ピナコールカップリング法
US4370494A (en) Converting enzyme inhibitors
JPH0662671B2 (ja) プロリン誘導体
US4386075A (en) Renally active tetrapeptides
JP2013528214A (ja) 結晶性エザチオスタット塩酸塩非溶媒和物ｄ型の調製
US20060019951A1 (en) Vacuolins
EP0103927B1 (fr) Inhibiteurs de conversion d'enzymes
JP3142993B2 (ja) 水溶性ベナスタチン誘導体及びその薬学的用途
CA2369654A1 (fr) Derives d'uree n-substitues-n'-substitues et compositions pharmaceutiques contenant ces derives